SCYNEXIS, Inc. (SCYX) Provides Update On Corporate Progress And First Quarter 2014 Financial Results
6/16/2014 7:39:38 AM
RESEARCH TRIANGLE PARK, N.C., June 16, 2014 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (Nasdaq:SCYX), a clinical-stage company focused on developing novel anti-infectives to address drug-resistant infections, today provided a corporate progress update and reported financial results for the quarter ended March 31, 2014.
Help employers find you! Check out all the jobs and post your resume.
comments powered by